VTE risk raised in first 3-6 months of testosterone treatmen
Men have a 63% elevated risk of developing a venous thromboembolism within their first few months of starting testosterone treatment, research* based on UK patients has shown – but their absolute risk of having a VTE during treatment remains quite small, and in any case the relative risk declines gradually but substantially after the first six months. The authors of the study, published online today by The BMJ, said overlooking the timing and duration of testosterone use in previous studies might have masked the association between testosterone use and cardiovascular events....